Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Psoriatic Arthritis Topic Center

News
Subcutaneous Ustekinumab Cost Rose 84% Under Medicare Part D, Set to Drop Under Negotiated Price Reduction
08/15/2024
Coverage changes omitted self-injected therapies from Part B, but new negotiated price will reduce costs 66-67%.
Coverage changes omitted self-injected therapies from Part B, but new negotiated price will reduce costs 66-67%.
Coverage changes omitted...
08/15/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
IL-17 and IL-23 Inhibitor Infection Risk Low in PsA, PsO
03/04/2024
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the...
03/04/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
Quiz
Quiz: Predictors of Psoriatic Arthritis
02/22/2024
Researchers developed the Psoriatic Arthritis Risk Estimation Tool (PRESTO) to predict the 1- and 5-year risk of developing psoriatic arthritis in patients with psoriasis. Take our quiz to test your knowledge on the subject!
Researchers developed the Psoriatic Arthritis Risk Estimation Tool (PRESTO) to predict the 1- and 5-year risk of developing psoriatic arthritis in patients with psoriasis. Take our quiz to test your knowledge on the subject!
Researchers developed the...
02/22/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
Understanding PsA-Associated Mortality
01/30/2024
A recent Swedish cohort study shed light on disparities observed in relation to sex, age, and disease duration, which significantly influence the mortality risk among patients with psoriatic arthritis.
A recent Swedish cohort study shed light on disparities observed in relation to sex, age, and disease duration, which significantly influence the mortality risk among patients with psoriatic arthritis.
A recent Swedish cohort study...
01/30/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
Ultrasound in the Management of PsA
01/29/2024
The findings suggest the interest of rheumatologists to use ultrasound in the management of psoriatic arthritis.
The findings suggest the interest of rheumatologists to use ultrasound in the management of psoriatic arthritis.
The findings suggest the...
01/29/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
Conference Coverage
Treat-to-Target Tapering of TNFi Studied for Noninferiority in PsA, axSpA
01/03/2024
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic...
01/03/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
Conference Coverage
Rebecca Haberman, MD, on Racial and Ethnic Determinants of Psoriatic Phenotypes and Disease Activity
01/02/2024
Dr Haberman characterized a cohort of patients with psoriatic arthritis to evaluate how race, ethnicity, and sex may inform features of clinical presentation, comorbidities, disease course and outcomes.
Dr Haberman characterized a cohort of patients with psoriatic arthritis to evaluate how race, ethnicity, and sex may inform features of clinical presentation, comorbidities, disease course and outcomes.
Dr Haberman characterized a...
01/02/2024
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
Late-Onset vs Early-Onset PsA
12/06/2023
Investigators compared the characteristics and disease burden of PsA between early-onset and late-onset groups. What did they find?
Investigators compared the characteristics and disease burden of PsA between early-onset and late-onset groups. What did they find?
Investigators compared the...
12/06/2023
Rheumatology & Arthritis
From Rheumatology & Arthritis
Conference Coverage
JAK Inhibitors for Psoriatic Arthritis? Results of the JAK-pot Study
12/05/2023
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been...
12/05/2023
Rheumatology & Arthritis
From Rheumatology & Arthritis
News
The Link Between High BMI and Risk of 5 Rheumatic Diseases
12/05/2023
A Swedish observational study found a positive association between BMI and different rheumatic diseases.
A Swedish observational study found a positive association between BMI and different rheumatic diseases.
A Swedish observational study...
12/05/2023
Rheumatology & Arthritis
From Rheumatology & Arthritis
Conference Coverage
PsA and PsO Affecting Work Productivity?
11/20/2023
Dr Nancy Shadick explains the disease burden of psoriatic arthritis and psoriasis that interferes with a patient’s worklife.
Dr Nancy Shadick explains the disease burden of psoriatic arthritis and psoriasis that interferes with a patient’s worklife.
Dr Nancy Shadick explains the...
11/20/2023
Rheumatology & Arthritis
From Rheumatology & Arthritis

Advertisement

News

News
IL-17 and IL-23 Inhibitor Infection Risk Low in PsA, PsO
03/04/2024
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the...
03/04/2024
Rheumatology & Arthritis
News
Understanding PsA-Associated Mortality
01/30/2024
A recent Swedish cohort study shed light on disparities observed in relation to sex, age, and disease duration, which significantly influence the mortality risk among patients with psoriatic arthritis.
A recent Swedish cohort study shed light on disparities observed in relation to sex, age, and disease duration, which significantly influence the mortality risk among patients with psoriatic arthritis.
A recent Swedish cohort study...
01/30/2024
Rheumatology & Arthritis
News
Ultrasound in the Management of PsA
01/29/2024
The findings suggest the interest of rheumatologists to use ultrasound in the management of psoriatic arthritis.
The findings suggest the interest of rheumatologists to use ultrasound in the management of psoriatic arthritis.
The findings suggest the...
01/29/2024
Rheumatology & Arthritis
News
Late-Onset vs Early-Onset PsA
12/06/2023
Investigators compared the characteristics and disease burden of PsA between early-onset and late-onset groups. What did they find?
Investigators compared the characteristics and disease burden of PsA between early-onset and late-onset groups. What did they find?
Investigators compared the...
12/06/2023
Rheumatology & Arthritis
News
The Link Between High BMI and Risk of 5 Rheumatic Diseases
12/05/2023
A Swedish observational study found a positive association between BMI and different rheumatic diseases.
A Swedish observational study found a positive association between BMI and different rheumatic diseases.
A Swedish observational study...
12/05/2023
Rheumatology & Arthritis
News
Paucity of Research Found for Nondrug Interventions for PsA
10/19/2023
Physical activity shows some positive effect on disease activity, well-being.
Physical activity shows some positive effect on disease activity, well-being.
Physical activity shows some...
10/19/2023
Rheumatology & Arthritis
PsA hand
News
PRESTO: New Tool Predicts Progression to PsA
10/16/2023
Researchers have created a simple tool to provide risk estimations for development of psoriatic arthritis among patients with psoriasis.
Researchers have created a simple tool to provide risk estimations for development of psoriatic arthritis among patients with psoriasis.
Researchers have created a...
10/16/2023
Rheumatology & Arthritis
News
Comorbidity, Cardiovascular Burden Elevated in Early Psoriatic Arthritis
09/27/2023
The most prevalent comorbidity in early PsA was dyslipidemia, which affected nearly two-thirds of patients.
The most prevalent comorbidity in early PsA was dyslipidemia, which affected nearly two-thirds of patients.
The most prevalent comorbidity...
09/27/2023
Rheumatology & Arthritis
depressed person
News
Probability of Biologic Persistence Differs With Order of Use in PsA
09/27/2023
Discontinuation of treatment was associated with age, mental health, and tender joint count, researchers found.
Discontinuation of treatment was associated with age, mental health, and tender joint count, researchers found.
Discontinuation of treatment was...
09/27/2023
Rheumatology & Arthritis
psoriasis on knees
News
Tool Predicts Risk of Developing PsA Among Patients With Psoriasis
09/24/2023
Prediction model shows "reasonable accuracy" in assessing the risk of patients with psoriasis developing psoriatic arthritis within 1 to 5 years.
Prediction model shows "reasonable accuracy" in assessing the risk of patients with psoriasis developing psoriatic arthritis within 1 to 5 years.
Prediction model shows...
09/24/2023
Rheumatology & Arthritis
News
Comparing Onset of Action of Therapies in Rheumatoid Arthritis
11/16/2024
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to...
11/16/2024
Rheumatology & Arthritis
News
Study Identifies Most Discriminative Ultrasound Lesions for Spondyloarthritis
09/11/2024
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
Active enthesitis was consistently linked with most clinical measures of spondyloarthritis disease activity and severity.
Active enthesitis was...
09/11/2024
Rheumatology & Arthritis
News
Unvaccinated Patients With Rheumatic Diseases Risked Severe COVID-19
08/07/2024
Throughout the pandemic, patients with rheumatic diseases who were not vaccinated against SARS-CoV-2 experienced more severe outcomes.
Throughout the pandemic, patients with rheumatic diseases who were not vaccinated against SARS-CoV-2 experienced more severe outcomes.
Throughout the pandemic,...
08/07/2024
Rheumatology & Arthritis
News
Car-T Cell Treatment in Refractory Autoimmune Disease
07/12/2024
CD19 CAR-T cell treatment shows long-term safety and efficacy in 3 different autoimmune diseases.
CD19 CAR-T cell treatment shows long-term safety and efficacy in 3 different autoimmune diseases.
CD19 CAR-T cell treatment shows...
07/12/2024
Rheumatology & Arthritis
News
Ultraprocessed Food Intake and SLE Incidence Among Women
07/12/2024
Sugar- and artificially sweetened-beverages were among the key contributors to heightened risk of developing systemic lupus erythematosus.
Sugar- and artificially sweetened-beverages were among the key contributors to heightened risk of developing systemic lupus erythematosus.
Sugar- and artificially...
07/12/2024
Rheumatology & Arthritis
News
SpA Screening Tools Not Applicable to All Patients With Extramusculoskeletal Symptoms
05/08/2024
A scoping review of screening tools for spondyloarthritis found need for a better, patient-oriented screening tool.
A scoping review of screening tools for spondyloarthritis found need for a better, patient-oriented screening tool.
A scoping review of screening...
05/08/2024
Rheumatology & Arthritis
News
IL-17 and IL-23 Inhibitor Infection Risk Low in PsA, PsO
03/04/2024
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the...
03/04/2024
Rheumatology & Arthritis
News
ACR Workgroup Recommends Annual Screening for Depression, Physical Function Among Patients With SLE
02/28/2024
New quality measures aim to address gaps and inequities in symptom recognition, care, and disease management of systemic lupus erythematosus.
New quality measures aim to address gaps and inequities in symptom recognition, care, and disease management of systemic lupus erythematosus.
New quality measures aim to...
02/28/2024
Rheumatology & Arthritis
News
Patient-Reported Outcomes in Ankylosing Spondylitis Correlate With Work Productivity
02/26/2024
Controlling pain and disease activity helps to improve productivity.
Controlling pain and disease activity helps to improve productivity.
Controlling pain and disease...
02/26/2024
Rheumatology & Arthritis
News
Eye Inflammation, Social Vulnerability Linked With Delayed axSpA Diagnosis
02/23/2024
Older age at the onset of symptoms was associated with shorter delays, researchers say.
Older age at the onset of symptoms was associated with shorter delays, researchers say.
Older age at the onset of...
02/23/2024
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

News
Consensus Statements Summarize Predictors of Pediatric Ulcerative Colitis Outcomes
01/21/2021
Consensus was reached for 31 statements regarding predictors of colectomy, acute severe colitis, chronically active pediatric UC, cancer, and mortality.
Consensus was reached for 31 statements regarding predictors of colectomy, acute severe colitis, chronically active pediatric UC, cancer, and mortality.
Consensus was reached for 31...
01/21/2021
Autoimmune
Pop Quiz: Types of Alopecia Areata
Quiz
Pop Quiz: Types of Alopecia Areata
11/24/2020
There are several types of alopecia areata. Do you know which one is the most common? Find out by taking our pop quiz.
There are several types of alopecia areata. Do you know which one is the most common? Find out by taking our pop quiz.
There are several types of...
11/24/2020
Autoimmune
News
Quality of Care for Patients With SLE Varies Widely Across the United States
10/05/2020
The researchers evaluated the performance of 5 quality measures, including renal disease screening and hydroxychloroquine prescribing, at 186 practices across the United States.
The researchers evaluated the performance of 5 quality measures, including renal disease screening and hydroxychloroquine prescribing, at 186 practices across the United States.
The researchers evaluated the...
10/05/2020
Autoimmune
News
Cachexia is Underrecognized in Patients With SLE
08/19/2020
Researchers identified several risk factors for cachexia in patients with systemic lupus erythematosus and how the syndrome can affect these patients.
Researchers identified several risk factors for cachexia in patients with systemic lupus erythematosus and how the syndrome can affect these patients.
Researchers identified several...
08/19/2020
Autoimmune
4 Questions About New and Emerging Therapeutic Agents for IBD
Q&As
4 Questions About New and Emerging Therapeutic Agents for IBD
07/11/2020
Stephen B. Hanauer, MD, from Northwestern Medicine, answers our questions about the optimal positioning of new medications for inflammatory bowel disease, which he discussed in his presentation at !AS 2020.
Stephen B. Hanauer, MD, from Northwestern Medicine, answers our questions about the optimal positioning of new medications for inflammatory bowel disease, which he discussed in his presentation at !AS 2020.
Stephen B. Hanauer, MD, from...
07/11/2020
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay In the Know

Autoimmune Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement